Novavax, Inc.
NVAX
$7.95
-$0.43-5.13%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -81.03M | -121.30M | 162.38M | -147.55M | -178.39M |
| Total Depreciation and Amortization | 12.52M | 12.70M | 11.13M | 12.15M | 10.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -56.00M | 16.15M | 25.53M | 17.58M | 40.41M |
| Change in Net Operating Assets | -48.65M | -52.37M | 115.23M | 34.27M | -49.59M |
| Cash from Operations | -173.16M | -144.81M | 314.27M | -83.56M | -176.78M |
| Capital Expenditure | -1.93M | -1.37M | -2.88M | -6.88M | -8.84M |
| Sale of Property, Plant, and Equipment | 192.64M | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -46.70M | 33.28M | -369.83M | -372.00K | -239.00K |
| Cash from Investing | 144.01M | 31.91M | -372.71M | -7.25M | -9.08M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.76M | -512.00K | -366.00K | -360.00K | -2.32M |
| Issuance of Common Stock | -- | 415.00K | 257.97M | 6.86M | 102.71M |
| Repurchase of Common Stock | -666.00K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 616.00K | -616.00K | 0.00 |
| Cash from Financing | -3.42M | -97.00K | 258.22M | 5.89M | 100.39M |
| Foreign Exchange rate Adjustments | -10.72M | 6.03M | -156.00K | -2.96M | 2.92M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -43.30M | -106.97M | 199.62M | -87.87M | -82.55M |
